SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152 | -47.9% | 64,201 | +5.2% | 0.00% | – |
Q2 2023 | $292 | -55.2% | 61,020 | -47.0% | 0.00% | -100.0% |
Q1 2023 | $652 | +2314.8% | 115,100 | +2228.5% | 0.00% | – |
Q4 2022 | $27 | -100.0% | 4,943 | -43.9% | 0.00% | – |
Q4 2021 | $73,000 | -94.8% | 8,818 | -85.8% | 0.00% | -100.0% |
Q3 2021 | $1,404,000 | +19.5% | 62,164 | +26.1% | 0.00% | 0.0% |
Q2 2021 | $1,175,000 | +74.9% | 49,282 | +51.0% | 0.00% | 0.0% |
Q1 2021 | $672,000 | +147.1% | 32,641 | +193.5% | 0.00% | – |
Q4 2020 | $272,000 | -73.9% | 11,121 | -69.8% | 0.00% | -100.0% |
Q3 2020 | $1,042,000 | +25950.0% | 36,826 | +2539.9% | 0.00% | – |
Q4 2019 | $4,000 | -86.2% | 1,395 | -84.7% | 0.00% | – |
Q2 2019 | $29,000 | +123.1% | 9,100 | +601.1% | 0.00% | -100.0% |
Q4 2017 | $13,000 | -95.1% | 1,298 | -92.2% | 0.00% | -90.9% |
Q3 2017 | $267,000 | +403.8% | 16,678 | +280.2% | 0.01% | +175.0% |
Q3 2016 | $53,000 | – | 4,387 | +19840.9% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 22 | -86.5% | 0.00% | – |
Q3 2015 | $4,000 | – | 163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |